HISTOPLASMA CAPSULATUM MACROPHAGE--GENETIC INTERACTIONS

荚膜组织浆细胞巨噬细胞--遗传相互作用

基本信息

  • 批准号:
    2519573
  • 负责人:
  • 金额:
    $ 28.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-09-30 至 1999-08-31
  • 项目状态:
    已结题

项目摘要

Histoplasma capsulatum , a pathogenic dimorphic fungus that causes pulmonary and systemic disease in the normal and compromised host, poses a particular threat to patients who are immunologically defective, particularly those with the Acquired Immunodeficiency Syndrome (AIDS). In the AIDS patient progressive disseminated histoplasmosis is a significant cause of morbidity and mortality. Histoplasma capsulatum causes disease by parasitizing and surviving within non-activated macrophages. Little is known about the mechanisms by which the fungus survives and thrives within this environment. By understanding the genetic bases of how H. capsulatum subverts the normal killing mechanism of the macrophage and creates an hospitable intracellular niche, it may be possible to design more effective therapies and vaccines that can be used to treat the compromised patient and those at high risk to develop disease. Histoplasma capsulatum invades the human host through the lungs. The ability to survive within alveolar macrophages is therefore the first obstacle the organism must overcome to cause infection and a prime target for therapeutic intervention. Macrophages are highly phagocytic cells that kill microbes they have ingested by production of reactive oxygen and nitrogen metabolites, synthesis of bactericidal peptides, and formation of lysosomal acid hydrolases. Intracellular pathogens have developed diverse strategies to survive within macrophages, and in recent years we have uncovered a few of the tricks that used to avoid macrophage killing. However, the mechanisms by which H. capsulatum achieves the goal of intracellular survival is less well delineated. It neither escape from phagosomes nor inhibit phagosome-lysosome fusion; rather, these organisms survive within phagolysosomes, and appear to alter the intraphagosomal environment by moderating the pH within this organelle. We do not understand the mechanism by which this occurs, nor do we know whether the phagocytic event that mediates the internalization of these yeast is equivalent to the paradigms that have been established primarily using opsonized erythrocytes. There are 4 goals in our application. We plan to: (1) isolate and identify genes that are turned on and the products that are expressed during the process of attachment to- and survival within- macrophage; (2) clone and sequence the amplified mRNAs and perform comparative analysis of the peptide sequences they code for and select those that have low homology frequency with human sequences; (3) clone and characterize selected cDNA sequences from 2 cDNA libraries made from mRNA purified during attachment to macrophage infection and then perform gene knock-out experiments to identify the role these genes play in attachment and survival; and (4) locate the position of the cloned genes in our H. capsulatum yeast artificial chromosome (YAC) library.
组织囊肿囊肿,一种致病的二态真菌,引起 正常和受损的宿主中的肺和全身性疾病,姿势 对免疫学上有缺陷的患者的特殊威胁, 特别是患有获得免疫缺陷综合征(AIDS)的人。在 艾滋病患者进行性散发性组织质症是重要的 发病率和死亡率的原因。组织囊肿囊肿会引起疾病 在未激活的巨噬细胞中寄生和存活。几乎没有 知道真菌在内部生存和繁荣的机制已知 这个环境。通过了解H. capsulatum的遗传基础 颠覆巨噬细胞的正常杀戮机制,并创建一个 热情好客的细胞内利基,可能有可能设计更多 可用于治疗受损的有效疗法和疫苗 患者和患有高风险的患者。 组织囊肿通过肺侵袭了人类宿主。这 因此,在肺泡巨噬细胞中生存的能力是第一个 生物体必须克服引起感染和主要目标的障碍 用于治疗干预。巨噬细胞是高度吞噬细胞 杀死微生物,它们通过产生活性氧和 氮代谢物,杀菌肽的合成和形成 溶酶体酸水解酶。细胞内病原体已经发展出多种多样 在巨噬细胞中生存的策略,近年来我们已经 发现了一些用于避免巨噬细胞杀死的技巧。 但是,H。capsulatum实现目标的机制 细胞内存活率不太明确。它没有逃脱 吞噬小体或抑制吞噬体 - 溶酶体融合;相反,这些生物 在吞噬物体内生存,似乎改变了阴道内的 环境通过调节该细胞器中的pH值。我们没有 了解发生这种情况的机制,我们也不知道是否 介导这些酵母内在化的吞噬事件是 相当于主要使用的范例 调子红细胞。 我们的应用中有4个目标。我们计划:(1)隔离并识别 打开的基因以及在 巨噬细胞内的附着和生存过程; (2)克隆和 序列放大的mRNA并进行比较分析 他们为肽序列编码并选择那些同源性较低的肽序列 人类序列的频率; (3)克隆并表征选定的cDNA 来自在附着过程中由mRNA制成的2个cDNA库的序列 进行巨噬细胞感染,然后进行基因敲除实验 确定这些基因在依恋和生存中的作用; (4) 找到克隆基因在我们的H. capsulatum酵母中的位置 人造染色体(YAC)图书馆。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Deuterium NMR investigation of an amphotericin B derivative in mechanically aligned lipid bilayers.
对机械排列的脂质双层中的两性霉素 B 衍生物进行氘核磁共振研究。
  • DOI:
    10.1016/s0005-2736(99)00223-0
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hing,AW;Schaefer,J;Kobayashi,GS
  • 通讯作者:
    Kobayashi,GS
Dimorphism in Histoplasma capsulatum and Blastomyces dermatitidis.
荚膜组织胞浆菌和皮炎芽生菌的二态性。
  • DOI:
    10.1159/000060346
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Maresca,B;Kobayashi,GS
  • 通讯作者:
    Kobayashi,GS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE S KOBAYASHI其他文献

GEORGE S KOBAYASHI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE S KOBAYASHI', 18)}}的其他基金

HISTOPLASMA CAPSULATUM MACROPHAGE--GENETIC INTERACTIONS
荚膜组织浆细胞巨噬细胞--遗传相互作用
  • 批准号:
    2234580
  • 财政年份:
    1995
  • 资助金额:
    $ 28.16万
  • 项目类别:
HISTOPLASMA CAPSULATUM MACROPHAGE--GENETIC INTERACTIONS
荚膜组织浆细胞巨噬细胞--遗传相互作用
  • 批准号:
    2234581
  • 财政年份:
    1995
  • 资助金额:
    $ 28.16万
  • 项目类别:
DIMORPHISM AND VIRULENCE IN HISTOPLASMA CAPSULATUM
荚膜组织胞浆菌的二态性和毒力
  • 批准号:
    3144481
  • 财政年份:
    1990
  • 资助金额:
    $ 28.16万
  • 项目类别:
DIMORPHISM AND VIRULENCE IN HISTOPLASMA CAPSULATUM
荚膜组织胞浆菌的二态性和毒力
  • 批准号:
    3144482
  • 财政年份:
    1990
  • 资助金额:
    $ 28.16万
  • 项目类别:
DIMORPHISM AND VIRULENCE IN HISTOPLASMA CAPSULATUM
荚膜组织胞浆菌的二态性和毒力
  • 批准号:
    3144480
  • 财政年份:
    1990
  • 资助金额:
    $ 28.16万
  • 项目类别:
DIMORPHISM AND VIRULENCE IN HISTOPLASMA CAPSULATUM
荚膜组织胞浆菌的二态性和毒力
  • 批准号:
    3144483
  • 财政年份:
    1990
  • 资助金额:
    $ 28.16万
  • 项目类别:
DIMORPHISM AND VIRULENCE IN HISTOPLASMA CAPSULATUM
荚膜组织胞浆菌的二态性和毒力
  • 批准号:
    2065098
  • 财政年份:
    1990
  • 资助金额:
    $ 28.16万
  • 项目类别:
ADDITIONAL DRUGS FOR TREATMENT OF CANDIDIASIS
治疗念珠菌病的其他药物
  • 批准号:
    3596047
  • 财政年份:
    1987
  • 资助金额:
    $ 28.16万
  • 项目类别:
DEVEL OF ADDITIONAL DRUGS FOR TREATMENT OF CANDIDIASIS
开发治疗念珠菌病的其他药物
  • 批准号:
    3596057
  • 财政年份:
    1987
  • 资助金额:
    $ 28.16万
  • 项目类别:
ADDITIONAL DRUGS FOR TREATMENT OF CANDIDIASIS
治疗念珠菌病的其他药物
  • 批准号:
    3596052
  • 财政年份:
    1987
  • 资助金额:
    $ 28.16万
  • 项目类别:

相似海外基金

Multilineage DAmFRET to investigate AD/ADRD protein phase behavior in neural tissue models
多谱系 DAmFRET 研究神经组织模型中 AD/ADRD 蛋白相行为
  • 批准号:
    10583428
  • 财政年份:
    2023
  • 资助金额:
    $ 28.16万
  • 项目类别:
Humanized MAPT knockin mouse models for frontotemporal dementia
额颞叶痴呆人源化 MAPT 敲入小鼠模型
  • 批准号:
    10303887
  • 财政年份:
    2021
  • 资助金额:
    $ 28.16万
  • 项目类别:
Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19
用于 COVID-19 下游疾病和治疗研究的新小鼠模型中 ACE2 和相关引发蛋白酶的人源化
  • 批准号:
    10155985
  • 财政年份:
    2021
  • 资助金额:
    $ 28.16万
  • 项目类别:
Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19
用于 COVID-19 下游疾病和治疗研究的新小鼠模型中 ACE2 和相关引发蛋白酶的人源化
  • 批准号:
    10322764
  • 财政年份:
    2021
  • 资助金额:
    $ 28.16万
  • 项目类别:
Nuclear Receptors in B Cell Tolerance and Humoral Immune Responses
B 细胞耐受和体液免疫反应中的核受体
  • 批准号:
    10626756
  • 财政年份:
    2020
  • 资助金额:
    $ 28.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了